NO963241D0 - Tolags blandinger - Google Patents
Tolags blandingerInfo
- Publication number
- NO963241D0 NO963241D0 NO963241A NO963241A NO963241D0 NO 963241 D0 NO963241 D0 NO 963241D0 NO 963241 A NO963241 A NO 963241A NO 963241 A NO963241 A NO 963241A NO 963241 D0 NO963241 D0 NO 963241D0
- Authority
- NO
- Norway
- Prior art keywords
- galactolipid
- samples
- room temperature
- highly viscous
- mixed
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 6
- 239000000463 material Substances 0.000 abstract 4
- 241000209140 Triticum Species 0.000 abstract 2
- 235000021307 Triticum Nutrition 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- KDYAPQVYJXUQNY-OPHDRXFHSA-N 1,2-di-(alpha-linolenoyl)-3-[alpha-D-galactosyl-(1->6)-beta-D-galactosyl]-sn-glycerol Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](OC[C@@H](COC(=O)CCCCCCC\C=C/C\C=C/C\C=C/CC)OC(=O)CCCCCCC\C=C/C\C=C/C\C=C/CC)O[C@@H]1CO[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KDYAPQVYJXUQNY-OPHDRXFHSA-N 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 235000013339 cereals Nutrition 0.000 abstract 1
- 238000004587 chromatography analysis Methods 0.000 abstract 1
- 239000006185 dispersion Substances 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 239000011521 glass Substances 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 239000002502 liposome Substances 0.000 abstract 1
- 239000002798 polar solvent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/064—Water-in-oil emulsions, e.g. Water-in-silicone emulsions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
- A23D7/0053—Compositions other than spreads
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L35/00—Food or foodstuffs not provided for in groups A23L5/00 – A23L33/00; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Birds (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coils Or Transformers For Communication (AREA)
- Magnetic Heads (AREA)
- Cosmetics (AREA)
- Organic Insulating Materials (AREA)
- General Preparation And Processing Of Foods (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9400368A SE9400368D0 (sv) | 1994-02-04 | 1994-02-04 | Glycolipid material |
| SE9402455A SE9402455L (sv) | 1994-07-12 | 1994-07-12 | Biskiktspreparat |
| PCT/SE1995/000116 WO1995020944A1 (en) | 1994-02-04 | 1995-02-06 | Bilayer preparations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO963241L NO963241L (no) | 1996-08-02 |
| NO963241D0 true NO963241D0 (no) | 1996-08-02 |
| NO312494B1 NO312494B1 (no) | 2002-05-21 |
Family
ID=26661955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19963241A NO312494B1 (no) | 1994-02-04 | 1996-08-02 | Anvendelse av en tolags lipid/polar-lösningsmiddelblanding, farmasöytisk blanding som omfatter tolagslipid/polarlösningsmiddelblanding, samt fremgangsmåte forfremstilling av en sådan |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6022561A (no) |
| EP (1) | EP0744939B1 (no) |
| JP (1) | JP3203358B2 (no) |
| CN (1) | CN1083713C (no) |
| AT (1) | ATE224704T1 (no) |
| AU (1) | AU691249B2 (no) |
| CA (1) | CA2182576C (no) |
| DE (1) | DE69528355T2 (no) |
| DK (1) | DK0744939T3 (no) |
| ES (1) | ES2183865T3 (no) |
| FI (1) | FI963065A (no) |
| HU (1) | HUT75459A (no) |
| MY (1) | MY113341A (no) |
| NO (1) | NO312494B1 (no) |
| NZ (1) | NZ279953A (no) |
| PL (1) | PL178438B1 (no) |
| PT (1) | PT744939E (no) |
| TW (1) | TW402502B (no) |
| WO (1) | WO1995020944A1 (no) |
Families Citing this family (77)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE504664C2 (sv) * | 1995-09-22 | 1997-03-24 | Scotia Lipidteknik Ab | Sätt att framställa fraktionerad olja, oljan, dess användning samt emulsionskomposition innehållande oljan |
| AR013065A1 (es) * | 1996-10-25 | 2000-12-13 | Monsanto Technology Llc | COMPOSICIoN Y METODO DE TRATAMIENTO PARA PLANTAS. |
| EP0941029B1 (en) | 1996-10-25 | 2002-09-18 | Monsanto Technology LLC | Composition and method for treating plants with exogenous chemicals |
| WO1998020884A1 (fr) * | 1996-11-08 | 1998-05-22 | Takara Shuzo Co., Ltd. | Inducteurs d'apoptose |
| WO1999012640A1 (en) * | 1997-09-09 | 1999-03-18 | Select Release, L.C. | Coated particles, methods of making and using |
| EP1043016B1 (en) * | 1999-03-30 | 2014-08-20 | Sodic Sa | A plant extract based on glycerides,phospholipids and phytosphingolipids, a method for the preparation of this extract and a cosmetic composition containing the same |
| FR2810540B1 (fr) * | 2000-06-21 | 2004-04-30 | C3D | Nouvelles preparations cosmetiques ou hygieniques sous forme de dispersion |
| FR2814071A1 (fr) * | 2000-09-21 | 2002-03-22 | Oreal | Composition a base de glycoglyceride et ses utilisations notamment cosmetiques |
| US6890255B2 (en) | 2001-12-17 | 2005-05-10 | Igt | Multiple wheel roulette game |
| DK1499294T3 (da) * | 2002-04-29 | 2010-12-06 | Biotesys Gmbh | Polymeriserede, peptid-modificerede lipider som biologiske transportsystemer til mikronæringsstoffer |
| US20040018237A1 (en) * | 2002-05-31 | 2004-01-29 | Perricone Nicholas V. | Topical drug delivery using phosphatidylcholine |
| US7731947B2 (en) * | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
| SE0300207D0 (sv) | 2003-01-29 | 2003-01-29 | Karolinska Innovations Ab | New use and composition |
| DE10336841A1 (de) * | 2003-08-11 | 2005-03-17 | Rovi Gmbh & Co. Kosmetische Rohstoffe Kg | Kosmetische Zusammensetzung zur Unterstützung des Sauerstofftransports in die Haut |
| SE0401942D0 (sv) * | 2004-07-28 | 2004-07-28 | Lipopeptide Ab | New antimicrobial peptide complexes |
| KR101376895B1 (ko) | 2004-05-03 | 2014-03-25 | 헤르메스 바이오사이언스, 인코포레이티드 | 약물 전달에 유용한 리포좀 |
| US8658203B2 (en) | 2004-05-03 | 2014-02-25 | Merrimack Pharmaceuticals, Inc. | Liposomes useful for drug delivery to the brain |
| US20050255154A1 (en) | 2004-05-11 | 2005-11-17 | Lena Pereswetoff-Morath | Method and composition for treating rhinitis |
| EP1846444A2 (en) | 2004-12-22 | 2007-10-24 | Lipopeptide AB | Agents inhibiting the cathelin-like protein cap18/ll-37 |
| WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
| US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
| DE102005023640A1 (de) * | 2005-05-19 | 2006-11-23 | Beiersdorf Ag | Wirkstoffkombinationen aus Glucosylglyceriden und einem oder mehreren partiell neutralisierten Ester von Monoglyceriden und / oder Diglyceriden gesättigter Fettsäuren mit Zitronensäure |
| DE102005023636A1 (de) * | 2005-05-19 | 2006-11-23 | Beiersdorf Ag | Wirkstoffkombinationen aus Glucosylglyceriden und Kreatin und / oder Kreatinin |
| DE102006015544A1 (de) * | 2006-03-31 | 2007-10-04 | Kuhs Gmbh | Topisch zu applizierende Zusammensetzung |
| KR101106510B1 (ko) | 2006-05-30 | 2012-01-20 | 인타르시아 세라퓨틱스 인코포레이티드 | 투피스, 내부채널 삼투압 전달 시스템 유동 조절기 |
| AU2007284759B2 (en) | 2006-08-09 | 2010-10-28 | Intarcia Therapeutics, Inc. | Osmotic delivery systems and piston assemblies |
| WO2008084253A1 (en) * | 2007-01-12 | 2008-07-17 | Lipopeptide Ab | Use of a galactolipid for wound and ulcer healing |
| RU2440097C2 (ru) | 2007-04-23 | 2012-01-20 | Интарсия Терапьютикс, Инк. | Способ лечения диабета ii типа и ожирения, осмотическое устройство для доставки и способ его изготовления |
| US20090137497A1 (en) * | 2007-11-23 | 2009-05-28 | Beiersdorf Ag | Active ingredient combinations of glucosyl glycerides and creatine and/or creatinine |
| DK2240155T3 (da) | 2008-02-13 | 2012-09-17 | Intarcia Therapeutics Inc | Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler |
| US20090285882A1 (en) * | 2008-04-22 | 2009-11-19 | Jochen Weiss | Stabilized Liposome Compositions and Related Methods of Use |
| EP2406361B1 (en) * | 2009-03-11 | 2021-01-20 | Swedish Oat Fiber AB | Method for separating neutral and polar lipids and an oil rich in polar lipids |
| EP3735944A1 (en) | 2009-09-28 | 2020-11-11 | Intarcia Therapeutics, Inc. | Rapid establishment and/or termination of substantial steady-state drug delivery |
| WO2011043008A1 (ja) * | 2009-10-07 | 2011-04-14 | パナソニック株式会社 | 人工脂質膜形成方法 |
| UA111147C2 (uk) | 2009-11-11 | 2016-04-11 | Байєр Б.В. | Способи та композиції для лікування або профілактики зовнішнього отиту |
| WO2011087403A1 (en) * | 2010-01-18 | 2011-07-21 | Lipidor Ab | Alcoholysis of glycolipid and corresponding lysis product |
| US9237762B2 (en) | 2010-05-24 | 2016-01-19 | Swedish Oat Fiber Ab | Aqueous dispersion comprising galactolipids and method for production thereof |
| US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
| JP2014508166A (ja) | 2011-03-17 | 2014-04-03 | トランスダーマル バイオテクノロジ インコーポレーテッド | 局所的一酸化窒素システム及びその使用方法 |
| US8871259B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Techniques and systems for treatment of neuropathic pain and other indications |
| US8871256B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Methods and systems for treatment of inflammatory diseases with nitric oxide |
| US8871255B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Treatment of skin and soft tissue infection with nitric oxide |
| US8871261B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Cancer treatments and compositions for use thereof |
| US8871262B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Compositions and methods for treatment of osteoporosis and other indications |
| US8871260B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Methods and compositions for muscular and neuromuscular diseases |
| US8871257B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery |
| US8871258B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Treatment and prevention of learning and memory disorders |
| US8871254B2 (en) | 2012-09-19 | 2014-10-28 | Transdermal Biotechnology, Inc. | Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system |
| US9295647B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
| US9314433B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
| US9314422B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
| US9687520B2 (en) | 2013-03-13 | 2017-06-27 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
| US9241899B2 (en) | 2013-03-13 | 2016-01-26 | Transdermal Biotechnology, Inc. | Topical systems and methods for treating sexual dysfunction |
| US9320706B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
| US9314423B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Hair treatment systems and methods using peptides and other compositions |
| US9339457B2 (en) | 2013-03-13 | 2016-05-17 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
| US9387159B2 (en) | 2013-03-13 | 2016-07-12 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
| US9750787B2 (en) | 2013-03-13 | 2017-09-05 | Transdermal Biotechnology, Inc. | Memory or learning improvement using peptide and other compositions |
| US9393264B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Immune modulation using peptides and other compositions |
| US9314417B2 (en) | 2013-03-13 | 2016-04-19 | Transdermal Biotechnology, Inc. | Treatment of skin, including aging skin, to improve appearance |
| US9295637B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Compositions and methods for affecting mood states |
| US20140271938A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Systems and methods for delivery of peptides |
| US20140271937A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
| US9849160B2 (en) | 2013-03-13 | 2017-12-26 | Transdermal Biotechnology, Inc. | Methods and systems for treating or preventing cancer |
| US20140271731A1 (en) | 2013-03-13 | 2014-09-18 | Transdermal Biotechnology, Inc. | Cardiovascular disease treatment and prevention |
| US9320758B2 (en) | 2013-03-13 | 2016-04-26 | Transdermal Biotechnology, Inc. | Brain and neural treatments comprising peptides and other compositions |
| US9393265B2 (en) | 2013-03-13 | 2016-07-19 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
| US9724419B2 (en) | 2013-03-13 | 2017-08-08 | Transdermal Biotechnology, Inc. | Peptide systems and methods for metabolic conditions |
| US9295636B2 (en) | 2013-03-13 | 2016-03-29 | Transdermal Biotechnology, Inc. | Wound healing using topical systems and methods |
| US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
| MA44390A (fr) | 2015-06-03 | 2019-01-23 | Intarcia Therapeutics Inc | Systèmes de mise en place et de retrait d'implant |
| CA3001467A1 (en) | 2015-10-16 | 2017-04-20 | Ipsen Biopharm Ltd. | Stabilizing camptothecin pharmaceutical compositions |
| WO2017200943A1 (en) | 2016-05-16 | 2017-11-23 | Intarcia Therapeutics, Inc. | Glucagon-receptor selective polypeptides and methods of use thereof |
| USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
| USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
| IL267736B2 (en) | 2017-01-03 | 2024-03-01 | Intarcia Therapeutics Inc | Methods involving continuous administration of a GLP-1 receptor agonist and co-administration of a drug |
| CN110183500B (zh) * | 2019-07-05 | 2022-09-09 | 湖北中医药大学 | 一种植物半乳糖脂的制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US437567A (en) * | 1890-09-30 | Cash and parcel carrier | ||
| EP0009842B1 (en) * | 1978-10-02 | 1982-11-10 | THE PROCTER & GAMBLE COMPANY | Liposomes for drug delivery and composition containing a liposome drug system |
| SE8206744D0 (sv) * | 1982-11-26 | 1982-11-26 | Fluidcarbon International Ab | Preparat for kontrollerad avgivning av substanser |
| DE3778972D1 (de) * | 1986-06-12 | 1992-06-17 | Liposome Co Inc | Mittel unter verwendung liposomverkapselter, nichtsteroider, antiinflammatorischer arzneistoffe. |
| US5234767A (en) * | 1987-03-13 | 1993-08-10 | Micro-Pak, Inc. | Hybrid paucilamellar lipid vesicles |
| ATE92765T1 (de) * | 1989-02-06 | 1993-08-15 | Chiba Flour Milling | Limulustest-positives pflanzenglykolipid und verfahren zur stimulierung des immunsystems eines tieres. |
-
1995
- 1995-02-06 JP JP52055695A patent/JP3203358B2/ja not_active Expired - Lifetime
- 1995-02-06 DK DK95909184T patent/DK0744939T3/da active
- 1995-02-06 AU AU17234/95A patent/AU691249B2/en not_active Ceased
- 1995-02-06 PL PL95315779A patent/PL178438B1/pl not_active IP Right Cessation
- 1995-02-06 NZ NZ279953A patent/NZ279953A/en unknown
- 1995-02-06 AT AT95909184T patent/ATE224704T1/de not_active IP Right Cessation
- 1995-02-06 EP EP95909184A patent/EP0744939B1/en not_active Expired - Lifetime
- 1995-02-06 ES ES95909184T patent/ES2183865T3/es not_active Expired - Lifetime
- 1995-02-06 HU HU9602146A patent/HUT75459A/hu unknown
- 1995-02-06 CN CN95192305A patent/CN1083713C/zh not_active Expired - Fee Related
- 1995-02-06 CA CA002182576A patent/CA2182576C/en not_active Expired - Fee Related
- 1995-02-06 WO PCT/SE1995/000116 patent/WO1995020944A1/en active IP Right Grant
- 1995-02-06 DE DE69528355T patent/DE69528355T2/de not_active Expired - Lifetime
- 1995-02-06 PT PT95909184T patent/PT744939E/pt unknown
- 1995-02-07 MY MYPI95000269A patent/MY113341A/en unknown
- 1995-02-13 TW TW084101255A patent/TW402502B/zh not_active IP Right Cessation
-
1996
- 1996-08-02 NO NO19963241A patent/NO312494B1/no not_active IP Right Cessation
- 1996-08-02 FI FI963065A patent/FI963065A/fi not_active IP Right Cessation
-
1998
- 1998-08-27 US US09/141,058 patent/US6022561A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP3203358B2 (ja) | 2001-08-27 |
| TW402502B (en) | 2000-08-21 |
| ATE224704T1 (de) | 2002-10-15 |
| CA2182576A1 (en) | 1995-08-10 |
| ES2183865T3 (es) | 2003-04-01 |
| NO963241L (no) | 1996-08-02 |
| CN1083713C (zh) | 2002-05-01 |
| DE69528355T2 (de) | 2003-05-15 |
| PL178438B1 (pl) | 2000-04-28 |
| MY113341A (en) | 2002-01-31 |
| EP0744939B1 (en) | 2002-09-25 |
| WO1995020944A1 (en) | 1995-08-10 |
| NZ279953A (en) | 1998-02-26 |
| FI963065A (fi) | 1996-09-30 |
| PT744939E (pt) | 2003-02-28 |
| CA2182576C (en) | 2002-09-17 |
| JPH09508414A (ja) | 1997-08-26 |
| PL315779A1 (en) | 1996-12-09 |
| FI963065A0 (fi) | 1996-08-02 |
| US6022561A (en) | 2000-02-08 |
| AU1723495A (en) | 1995-08-21 |
| EP0744939A1 (en) | 1996-12-04 |
| AU691249B2 (en) | 1998-05-14 |
| DK0744939T3 (da) | 2003-02-03 |
| CN1144478A (zh) | 1997-03-05 |
| DE69528355D1 (de) | 2002-10-31 |
| HUT75459A (en) | 1997-05-28 |
| HU9602146D0 (en) | 1996-09-30 |
| NO312494B1 (no) | 2002-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO963241D0 (no) | Tolags blandinger | |
| ES2186792T3 (es) | Metodos de fabricar liposomas que contienen fotosensibilizantes hidro-monobenzoporfirinicos. | |
| ES8606659A1 (es) | Un metodo para detectar anticuerpos en suero o fluido | |
| NO922735L (no) | Interdigitasjon-fusjon liposomer og geler | |
| Stevenson et al. | Electrophoretic and Chromatographic Investigations of Clay‐adsorbed Organic Colloids: 1. Preliminary Investigations | |
| FI951811A0 (fi) | Lomisormitus-fuusioliposomit ja -geelit | |
| AU5933080A (en) | 1-alkadienyl-2hydroxymethyl-3,4,5-trihydroxy- piperidine compounds | |
| Klass | Immunochemical studies of the protein fraction of pulmonary surface active material | |
| Ferguson et al. | Effects of vasopressin on toad bladder membrane proteins: Relationship to transport of sodium and water | |
| Weiner et al. | Interactions of dimethyl sulfoxide with lipid and protein monolayers | |
| Whysner et al. | Purification of the lethal fraction of the venom of the marine snail Conus californicus | |
| Viljoen et al. | The detection and isolation of a paralysis toxin present in Argas (Persicargas) walkerae | |
| TW378271B (en) | The method of quantitative analysis of thuringiensin by capillary electrophoresis | |
| Cebra | Starch block electrophoresis of ragweed pollen antigens | |
| BE876160A (fr) | Procede de preparation de 1,5-dimethylbicyclo(3.2.1.)-octanol-8 et nouveaux esters de cet alcool | |
| Davis et al. | Micellar capillary electrophoresis of the ecdysteroids | |
| Nugent et al. | Candidacidal factors in murine bronchoalveolar lavage fluid | |
| Plantner et al. | Multiple isoelectric forms of detergent-solubilized bovine rhodopsin: I. Identity, composition and properties | |
| Zeineh et al. | Immunocore electrophoresis as a purity test for albumin | |
| Schumann | Immunogenetic and electrophoretic studies with extracts of different adult Culex pipiens strains | |
| Procházka et al. | The antigenic structure of Francisella tularensis: II. Fractionation of the ether antigen on cellulose carriers and by gel filtration | |
| BR8403837A (pt) | Processo de manufatura de alcool pelo uso de levedo exterminador no alcool | |
| KR890006145A (ko) | 니코틴 살충제 제조방법 | |
| Van Der Linde et al. | Role of membrane lipid composition in the cytotoxicity of the sesquiterpene lactone eupatoriopicrin | |
| TH24388A (th) | วิธีการทำให้สิ่งเจือปนแขวนลอย และสารผสมที่ผลิตโดยวิธีน้ำ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |